Navigation Links
Lilly Announces 2014 Financial Guidance, Reconfirms 2013 Expectations
Date:1/7/2014

order to adequately fund R&D, invest in the launch of new products, support necessary capital spending, engage in business development and return additional cash to shareholders through our dividend and our share repurchase program. We believe our strategy is the right one for Lilly and one that will continue to create value for all of our stakeholders."

"With the U.S. patent expiration of Cymbalta last December and that of Evista coming in March, we expect 2014 to be the most financially challenging year of Lilly's current period of patent expirations," said Derica Rice, Lilly executive vice president, global services and chief financial officer. "We are prepared for this challenge and are positioned to return to growth and expand margins in 2015 and beyond."

2014 Financial Guidance
The company expects full-year 2014 earnings per share to be in the range of $2.77 to $2.85 on both a reported basis and non-GAAP basis. Earnings per share expectations for 2014 reflect completed share repurchases from 2013 (including $500 million completed in the fourth quarter of 2013) and potential share repurchases in 2014.

The company anticipates 2014 revenue of between $19.2 billion and $19.8 billion. Patent expirations are expected to drive a substantial decline in U.S. Cymbalta® and U.S. Evista® sales. These revenue declines are expected to be partially offset by growth from a portfolio of other products including Humalog®, Trajenta®, Cialis®, Forteo® and Alimta®, as well as the animal health business. In addition, strong revenue growth is expected in China, while a weaker Japanese yen will dampen revenue growth in Japan.

The company anticipates that gross margin as a percent of revenue will be approximately 74 percent in 2014.

Total operati
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lilly Sets Dates and Conference Calls for 2014 Financial Guidance and Fourth-Quarter 2013 Financial Results Announcements
2. Lilly to Present at J.P. Morgan Healthcare Conference
3. Lilly Declares First-Quarter 2014 Dividend
4. Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America
5. Lilly Announces Edivoxetine Did Not Meet Primary Endpoint of Phase III Clinical Studies as Add-On Therapy for Major Depressive Disorder
6. Zacks Industry Outlook Highlights: Merck, Pfizer, Forest Laboratories, Sanofi and Eli Lilly
7. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
8. Surveyed Endocrinologists Consider Eli Lillys Dulaglutide To Have an Edge Over Competitors for the Treatment of Type 2 Diabetes Patients Who Are Inadequately Controlled On Metformin
9. Lilly Statement on Contribution to Indiana Biosciences Research Institute
10. Lilly Announces Significant Global Insulin Manufacturing Capacity Investments in Response to Growing Diabetes Epidemic
11. Medtronic, Lilly Diabetes Join Together as First Ever National Presenting Sponsors of the JDRF Walk To Cure Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015   Decision Resources Group ... identify less frequent dosing as the highest unmet ... the burden on both patients and providers associated ... (VEGF) injections, which are the current standard of ... which is in development for dosing every two ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/8mfjxh/2015_new ) has announced the addition of ... Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, ... 2015 New Frontiers in Clinical ... Competitive Landscape is a new seven-country strategic ...
(Date:7/2/2015)... , 2 de julio de 2015 ... ADN de alto rendimiento en ... American College of Pathologists (CAP). La instalación de BGI en ... laboratorio de secuenciación de próxima generación que recibe la ... el más alto estándar en prácticas de laboratorio clínico. ...
Breaking Medicine Technology:Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2BGI recibe la acreditación del College of American Pathologists (CAP) 2
... 2, 2011 The Unilens Vision Inc. (OTCBB: UVIC) ... today declared a quarterly cash dividend of $0.045 per common share, ... the close of business on May 13, 2011. ... Lens Company" Established in 1989, Unilens Vision Inc., ...
... Amira Pharmaceuticals, Inc. announced today ... AM152, the Company,s oral selective antagonist of the LPA1 receptor. ... 2a study in patients suffering from systemic sclerosis, a systemic ... clinical study in healthy volunteers demonstrated that AM152 is safe ...
Cached Medicine Technology:Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share 2Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist 2
(Date:7/2/2015)... VA (PRWEB) , ... July 02, 2015 , ... sweetFrog ... Albany, Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium ... growing companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker ... at the University of Minnesota, they knew it would save the university energy ... an award-winning choice: the total energy savings after installation was an impressive 89 ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth of July outdoors ... is on the rise. July is UV Safety Month, and physicians at American Family ... of getting skin checks. Experts say most skin cancers can be found early with ...
(Date:7/2/2015)... ... 02, 2015 , ... ActiveBunch.com recently launched as a social network created for ... as a lifestyle community, Active Bunch allows users to connect with like-minded fitness enthusiasts ... in discussions or group events. , The spokesperson for Active Bunch explained the ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... with care and precision. There is an art and science that goes into ... of successfully reshaping the facial features and lives of more than 2,500 satisfied ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3
... residing in the the human intestinal tract may be ... Scientists from the University of Florida present their research ... Society for Microbiology in San Diego, CA. "Our ... detected in subjects with polyps, early lesions that can ...
... ... joined forces to launch a new awards program sponsored by Jackson Healthcare. The Hospital ... charitable hospital programs in the U.S. , ... Atlanta, GA (Vocus) May 25, 2010 -- A group of senior healthcare ...
... BOSTON (May 25, 2010) Longtime environmental health ... the carcinogenic effects of endocrine-disrupting chemicals (EDCs), ubiquitous ... In a review article published online May 25 ... express the need for more complex strategies for ...
... have developed a new influenza vaccine that brings science one ... the need for seasonal flu shots. The new findings ... , the first online, open-access journal published by the American ... only a narrow range of influenza virus strains," said Peter ...
... ,presumed consent, and priority for those who pledge to donate ... thousands of lives every year, but many more people languish ... While proposals to increase the supply have gained some ... even if they should be tried at all. , "The ...
... ... become published authors, and earn money for college, by entering the B’nai B’rith International ... aimed at teaching grade-schoolers about tolerance and diversity. The winners take home $5,000 college ... ...
Cached Medicine News:Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 2Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 3Health News:Senior Healthcare Executives to Lead Hospital Charitable Service Awards 4Health News:Endocrine-disrupting chemicals pose cancer risk 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 2Health News:Shortage of Transplant Organs Spurs Proposals But No Solution 3Health News:High School Students Well-Schooled In Diversity: Teen Winners of Book Writing Contest Earn College Scholarships and Have Entries Published 2
... decade KMI® revolutionized the wrist arthroplasty market ... Wrist System. We're at it again, with ... the Universal2. Like the original, the Universal2 ... live with debilitating arthritis. To date, we ...
... Carl Zeiss has successfully advanced into the ... success of this instrument is by no ... and stylish design. Maximum ergonomic convenience is ... be used with a surgical microscope, allowing ...
Athroscopic leg holder system....
The 300 watt Xenon light source will provide intense illumination necessary for demanding, advanced endoscopic procedures....
Medicine Products: